Kamada Ltd. announced FDA approval of its plasma collection center in San Antonio, Texas, following a February 2026 inspection, clearing it for commercial sales of normal source plasma. The 11,100 square foot facility has an annual capacity of approximately 50,000 liters and is expected to generate $8 million to $10 million in annual revenue at full capacity.
Key takeaways
FDA approved Kamada Plasma’s San Antonio, TX collection center after February 2026 on-site inspection
San Antonio center cleared to commence commercial sales of normal source plasma
Facility supports up to 50 donor beds with annual collection capacity of approximately 50,000 liters
Expected to generate $8 million to $10 million annual revenue from normal source plasma sales at full capacity
Anticipated to be one of the largest U.S. centers for specialty plasma collection such as Anti-Rabies and Anti-D
Kamada now operates three FDA-approved Texas plasma centers: Houston, San Antonio, and Beaumont